Page last updated: 2024-10-22

6-acetylaminocaproic acid and Alveolitis, Fibrosing

6-acetylaminocaproic acid has been researched along with Alveolitis, Fibrosing in 2 studies

6-acetylaminocaproic acid: wound-healing agent component of plasmutan

Research Excerpts

ExcerptRelevanceReference
"Acexamic acid is currently used to avoid pulmonary fibrosis in patients treated with bleomycim."1.26[So-called refractory hypoxemia: treatment with acexamic acid]. ( Barale, F; Berthout, P; Boillot, A; Bourgeois, F; Daoudal, P, 1979)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bronner, G1
Litzler, A1
Conraux, C1
Daoudal, P1
Boillot, A1
Berthout, P1
Bourgeois, F1
Barale, F1

Other Studies

2 other studies available for 6-acetylaminocaproic acid and Alveolitis, Fibrosing

ArticleYear
[Anti-pulmonary fibrosis effect of acexamic acid in bleomycin therapy].
    Journal francais d'oto-rhino-laryngologie; audiophonologie, chirurgie maxillo-faciale, 1980, Volume: 29, Issue:7

    Topics: Aminocaproates; Aminocaproic Acid; Animals; Antifibrinolytic Agents; Bleomycin; Drug Therapy, Combin

1980
[So-called refractory hypoxemia: treatment with acexamic acid].
    La Nouvelle presse medicale, 1979, Dec-03, Volume: 8, Issue:47

    Topics: Adolescent; Adult; Aminocaproates; Aminocaproic Acid; Bleomycin; Female; Humans; Hypoxia; Male; Midd

1979